Target intelligence / Profile preview

Ras-related protein Rab-3C (RAB3C)

Target
RAB3C
Molecular classification
Small GTPase, Rab GTPase family, Ras small GTPase superfamily, P-loop containing nucleoside triphosphate hydrolase, Synaptic vesicle protein (functional context)
01

Overview

Ras-related protein Rab-3C (RAB3C) is a small GTPase of the Rab family, involved in the regulation of intracellular vesicular trafficking and controlled exocytosis of vesicles, particularly in secretory pathways. It is highly conserved and expressed in tissues such as the brain, placenta, and lung. Rab3C is essential for recycling receptors and phagocytosed molecules (such as MHC class I) to the cell surface and facilitates antigen cross-presentation within dendritic cells. In cancer, especially colorectal cancer, Rab3C overexpression is linked to increased exocytosis, chemoresistance, and poor prognosis. Its role in vesicle formation and trafficking puts it at the crossroad of fundamental cellular processes and clinically relevant disease mechanisms, marking it as a molecular target of interest for cancer and possibly for immune modulation.

Other names
Rab3CRAB3CRas-related protein Rab-3Cmember RAS oncogene family
02

Mechanism of action

Modulation of vesicular exocytosis, leading to altered drug sensitivity/resistance in cancer cells (e.g., targeting the Rab3C–dystrophin axis and influencing PI3KCA signaling; reversal of chemoresistance via CB2 agonists). Enhanced vesicle formation and packaging, which impacts drug response.

03

Biological functions

Regulation of vesicular traffickingControlled exocytosis of secretory vesiclesRecycling of phagocytosed MHC class I complexes to the cell surfaceAntigen cross-presentation (in dendritic cells)GTP binding and hydrolysisMyosin V binding
04

Disease associations

Cancer (e.g., colorectal carcinogenesis, chemoresistance in colorectal cancer)Cerebral angioma and brain angiomaMetastasis promotion (via IL6-STAT3 pathway in colon cancer)Other cellular proliferation and movement disorders (functional context)
05

Safety considerations

Therapeutic targeting of intracellular trafficking proteins like Rab3C may pose risks for normal cellular secretion and immune functionPotential impact on antigen presentation and immune response due to its role in MHC recyclingOverexpression correlates to adverse clinical outcomes in cancer, complicating therapy
06

Interacting drugs

Cannabinoid receptor 2 agonists (CB2 agonists)
07

Biomarkers

Overexpression of Rab3C in colorectal cancer tissue is associated with poor prognosis and may serve as a predictive biomarker for drug resistance

Beyond the preview

Go deeper on Ras-related protein Rab-3C (RAB3C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related protein Rab-3C (RAB3C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call